In a groundbreaking exploration published in the Journal of Epidemiology & Community Health, researchers have unveiled a pioneering approach to colorectal cancer surveillance that harnesses the power of wastewater analysis. This innovative technique could revolutionize how communities monitor and respond to colorectal cancer incidence, potentially enabling earlier detection and targeted public health interventions. With colorectal cancer ranking as the third most common cancer and the second leading cause of cancer-related deaths in the United States, such an advancement carries significant implications for disease management and prevention.
Colorectal cancer’s stealthy progression and often late-stage diagnosis have made traditional screening a challenging endeavor, despite the availability of colonoscopy and stool-based testing methods. One of the critical hurdles in combating this disease lies in achieving high individual compliance to screening regimens, which is complicated by various social determinants and structural barriers within communities. To circumvent these challenges, the research team investigated whether molecular markers of colorectal cancer could be detected and quantified in community wastewater, offering a non-invasive, population-wide early warning system.
Wastewater has long been recognized as a valuable reservoir of biological signatures, encompassing a myriad of substances excreted in feces and urine. Prior research has applied wastewater epidemiology to track viral outbreaks and community drug use, but its application to cancer biomarkers in a population surveillance context is pioneering. The study centered on CDH1, a gene associated with cancer progression, particularly colorectal cancer. This gene’s product plays a pivotal role in cell adhesion, and its aberrant expression is a hallmark of several cancers, making it an attractive biomarker candidate for monitoring.
The researchers conducted their study in Jefferson County, Kentucky, analyzing patient records and state cancer registry data over a span of nearly three decades. Geospatial mapping techniques identified clusters with significantly elevated colorectal cancer incidence, demarcated by regions having at least four cases within a half-mile radius. These clusters were then juxtaposed with low-incidence control regions, providing a comparative framework to assess the feasibility of wastewater marker detection correlating with disease prevalence.
Sampling was meticulously designed to capture the diurnal variation in wastewater composition. Researchers collected 175 milliliters of wastewater from four distinct sewersheds representing high and low disease incidence zones, at three time points—7 AM, 10 AM, and 1 PM—on a single day in late July 2023. These samples underwent rigorous molecular analysis targeting human RNA biomarkers. Specifically, CDH1 levels were measured alongside GAPDH, a ubiquitous housekeeping gene involved in glycolytic metabolism, which functioned as an internal control to normalize the cancer marker data, compensating for variability in sample content.
The findings revealed that all sampled sewersheds contained detectable levels of both CDH1 and GAPDH transcripts. Notably, the average ratio of CDH1 to GAPDH was markedly elevated in high-incidence clusters. One cluster exhibited ratios nearly an order of magnitude greater than the comparison group, suggesting that wastewater analysis could indeed reflect underlying cancer prevalence at a community level. Intriguingly, one cluster with the highest known colorectal cancer patient density showed a CDH1/GAPDH ratio nearly eight times that of the control area, mirroring clinical data and lending credence to the method’s sensitivity.
Yet, the study authors exercise caution in interpreting these results, highlighting the exploratory nature of the work as a proof of concept. The precise relationship between the CDH1:GAPDH ratio in wastewater and the incidence or stage distribution of colorectal cancer remains to be delineated. Additionally, the method cannot distinguish between newly diagnosed, ongoing, or undiagnosed cases, representing a limitation for epidemiological interpretation. The study’s relatively small sample size and confinement to a single geographical area further temper the generalizability of the findings and underscore the necessity for larger-scale validation.
Furthermore, there exist technical challenges intrinsic to wastewater-based surveillance of cancer biomarkers. RNA molecules are inherently unstable and susceptible to degradation in the environmental milieu of sewage systems. Effective detection thus requires sensitive extraction and amplification protocols capable of discerning low-abundance transcripts amidst a complex chemical background. Additionally, variations in population size, wastewater flow rates, and contributions from non-residential sources introduce confounding factors that must be rigorously accounted for in analytical modeling.
Despite these challenges, the potential advantages of wastewater surveillance for colorectal cancer are compelling. It offers a scalable and cost-efficient means to monitor disease trends at the population level, potentially identifying emerging hotspots that warrant focused screening efforts. Detecting elevated cancer markers in wastewater before clinical cases are registered in state databases could provide public health officials with lead-time, enabling more proactive and localized interventions. This methodological complement could be especially impactful in reaching underserved communities where access to traditional screening is limited.
The study’s authors emphasize that burgeoning colorectal cancer rates among younger populations necessitate novel public health strategies. While existing modalities like colonoscopies remain gold standards, their reliance on individual participation restricts their reach. Wastewater surveillance circumvents this barrier, offering a community-wide lens that does not depend on self-reporting or healthcare engagement, thus democratizing early detection capabilities. Integrating molecular data from sewage with epidemiological frameworks could herald a new paradigm in cancer surveillance and prevention.
Looking forward, the researchers advocate for comprehensive research agendas that address current knowledge gaps. Key priorities include refining biomarker panels to improve specificity and sensitivity, standardizing sampling protocols to account for temporal and spatial variability, and developing predictive models correlating wastewater signals to population disease metrics. Multisite studies encompassing diverse demographics and environmental contexts will be essential to validate and optimize this promising approach. Interdisciplinary collaboration across molecular epidemiology, environmental sciences, and clinical oncology will be imperative to realize its full potential.
This pioneering investigation inaugurates a horizon where wastewater monitoring transcends infectious disease tracking and enters the realm of chronic disease surveillance, shining light on cancer detection at a community scale. The prospect of harnessing municipal sewage as a mirror reflecting collective health status charts a bold course towards more timely, equitable, and effective cancer control strategies. While nascent, the promise embodied in wastewater-based colorectal cancer surveillance signals a transformative advancement in public health diagnostics.
Subject of Research: People
Article Title: Using wastewater for population-level colorectal cancer surveillance: a future research agenda
News Publication Date: 17-Mar-2026
Web References: http://dx.doi.org/10.1136/jech-2025-224253
Keywords: Colorectal cancer, Wastewater, Biomarkers, CDH1, Epidemiology, Public health surveillance, Early cancer detection, Molecular biology, Environmental health
